Homozygous Familial Hypercholesterolaemia or HoFH is characterised as an inherited disorder. It involves disturbances in lipid metabolism and is related to higher levels of LDL (low-density lipoprotein).
There are treatment medications available for the treatment of HoFH. The costs of such medications vary based on several factors, including manufacturing costs and the quantity of drugs prescribed by the healthcare provider.
Every patient with HoFH needs to consult a lipid specialist for advanced management of the condition. The primary goal of HoFH treatment is to decrease mortality. It also prevents or limits the progression of ASCVD (Atherosclerotic Cardiovascular Disease). Here are a few popular medications that get prescribed for treating HoFH:
Here is an overview of Homozygous Familial Hypercholesterolaemia medication costs:
| Drug Class | Drug Names | Estimated Costs |
| Statin | Rosuvastatin | Rs. 226 (10mg) |
| Atorvastatin | Rs. 84.94 (per stripe) | |
| PCSK9 Inhibitors | Alirocumab | Rs. 1.25 lakhs - Rs. 1.50 lakhs |
| Evolocumab | Rs. 21,111 (per piece) | |
| Cholesterol Absorption Inhibitor | Ezetimibe | Rs. 229.60 (10 mg) |
| ANGPTL3 Inhibitor | Evinacumab-dgnb | Rs. 70,000 per bottle |
Disclaimer: The prices listed in the table above have been taken from third-party sources and may vary in real time.
Apart from pharmacological methods, there are also other ways of treating HoFH. Here are a few of such methods:
The majority of LDL-R, about 70%, is present in the liver. LDL-R is a low-density lipoprotein receptor, and it plays a big role in cholesterol metabolism. Hence, liver transplantation (LT) is a therapeutic option for patients with HoFH as the dysfunctional receptors then get replaced with the normal ones from the donor.
Lipoprotein-apheresis is also an effective therapeutic procedure for treating HoFH. It is the ideal option for treatment for both children and adults who have severe cases that do not respond to medications. The ideal age for starting Lipoprotein-Apheresis (LA) is before the involvement of the aorta begins. This procedure is performed on affected individuals every week.
HoFH can lead to the rapid development of ASCVD and other premature heart-related events. Hence, it is necessary to consult a specialist promptly to get it checked for optimal health outcomes.